Developer docs
API playgroundTry for free, no card

Search company profiles

ROSIA-PCP

Full company profile

uuid003673j

Namestring
ROSIA-PCP
Legal namestring
Instituto Aragonés de Ciencias de la Salud (IACS)
Websiteurl
rosia-pcp.eu
Company typeenum
Private
Founded yearint
2021
Descriptiontext

ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative coordinated by the Instituto Aragonés de Ciencias de la Salud (IACS), a public research entity under the Aragon Health Department in Zaragoza, Spain. Funded by the European Commission's Horizon 2020 programme under grant agreement No 101017606, the project runs for 54 months (January 2021 through December 2025) with a €5 million budget, of which €3.9 million is allocated to a competitive three-phase R&D tender (Solution Design, Prototype Development, Field Testing). Its buyer group consists of three public healthcare procurers—Servicio Aragonés de Salud (Spain), Unidade Local de Saúde de Coimbra (Portugal), and the National Rehabilitation Hospital (Ireland)—who jointly steer the development of an open telerehabilitation platform for patients in rural and isolated parts of Europe. The 12-partner consortium spans five countries and includes research centres (Eurecat, CERTH/ITI, IGTP, IPN, IFIC), consultancies (VALDE Innova, The Decision Group, IEXP, PPCN), two Portuguese municipalities (Penela, Soure), and a facilitation partner (Eoh-for-Good).

The platform architecture is centred on an open integration layer that combines a service and device catalogue, SDK/APIs for third-party developers, a governance and quality-management system, and a shared care-plan interface for clinicians and patients. Functional components include patient self-management apps, AI-driven recommender systems across the four health pillars, decision support for risk stratification, VR/AR-enabled immersive rehabilitation, inertial-sensor-based monitoring, and a shared care plan with patient management for healthcare teams. Two Phase 3 solutions are being field-tested: REHABILIFY (led by Fundació Eurecat with Doole Health and IGTP) and RAISE (led by CERTH with TELEVES, IBV, Vidavo, University of Ioannina, and INESCTEC), covering seven pathologies—chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19—with over 100 patients piloted across rural Aragón, Coimbra, and Dublin.

The business model is public R&D procurement rather than commercial sales: ROSIA-PCP does not sell the platform; the three procurers act as anchor demand-side participants, and suppliers are selected through open competition. Marketing and stakeholder engagement span the project website, LinkedIn, X, Facebook, YouTube, newsletters, Open Market Consultation events, an online matchmaking platform, co-creation sessions, and a December 2025 end-of-project policy workshop with European Commission representation. Strategic positioning post-2025 depends on commercial uptake of the open platform by additional European public healthcare systems—a step that would be enabled by the certification, evidence, and policy outputs of the project but is not yet contracted.

Short descriptiontext

ROSIA-PCP is an EU Horizon 2020-funded Pre-Commercial Procurement project that develops an open telerehabilitation platform for patients in rural Europe. Coordinated by Spain's IACS and procured jointly by public health systems in Spain, Portugal, and Ireland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersZaragoza, Spain
HQ citystring
Zaragoza
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
telerehabilitation platform, open health ecosystem, remote rehabilitation services, digital health platform, pre-commercial procurement
Industry1 code
1Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
CodeHLAGACAHPrimaryYes
NAICS code3 codes
  • Home Health Care Services62161
  • Computer Systems Design and Related Services5415
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Home Health Care Services8082
  • Services-Computer Integrated Systems Design7373
  • Services-Commercial Physical & Biological Research8731
Product category
Telerehabilitation Software Platform
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Rehabilify
Description

Telerehabilitation solution developed by a Spanish Consortium led by Fundació Eurecat, involving Doole Health and Germans Trias i Pujol research centre (IGTP)

rosia-pcp.eu
+1 more record
Core offering1 text field

ROSIA-PCP is a Pre-Commercial Procurement (PCP) project that designs, procures, and field-tests an open telerehabilitation platform for patients in rural and isolated areas of Europe. It jointly procures R&D services from technology providers across three European public healthcare systems (Spain, Portugal, Ireland) through a three-phase competitive process, ultimately delivering an open platform with a catalogue of integrated rehabilitation apps, services, and devices that supports patient self-management and clinical remote monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 100 patients across Spain, Portugal, and Ireland tested the ROSIA solutions during the pilot phase, covering 7 pathologies including spinal cord injury, brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19.
+2 more records
Product overview1 text field

ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative developing an open innovation platform for telerehabilitation in remote rural areas. The offering is structured as a platform-plus-modules architecture centered on the ROSIA Open Platform, which integrates third-party solutions through an app and service catalogue. Two main Phase 3 solutions (REHABILIFY and RAISE) are being field-tested alongside legacy Phase 1/2 solutions (PROHAB, ULTREIA, RehabilityOpen, REHABILITA+). The ecosystem includes patient self-management tools, AI-powered recommender systems, decision support for clinicians, and SDK/APIs for developers to build and integrate rehabilitation applications. Seven pathologies are targeted: chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardio-vascular disease, hip fracture, and COVID-19.

Product and service6 records
1ROSIA Open Platform
CategoryTelerehabilitation Platform
Description

The main ROSIA open telerehabilitation platform designed to integrate third-party solutions, devices, and apps into a catalogue for clinical prescription by healthcare professionals. It enables healthcare systems to deploy hybrid telerehabilitation services within integrated care pathways across rural and remote patient populations.

2REHABILIFY (evolved from PROHAB)
CategoryTelerehabilitation Solution
Description

Phase 3 telerehabilitation solution developed by a Spanish consortium led by Fundació Eurecat, including Doole Health and Germans Trias i Pujol research centre (IGTP). Provides an open platform with a Patient Management System, AI recommender services, and SDK/APIs that enable third-party integration of rehabilitation technology.

3RAISE
CategoryTelerehabilitation Solution
Description

Phase 3 telerehabilitation solution developed by an international consortium led by CERTH (Centre for Research and Technology Hellas), integrating TELEVES, IBV, Vidavo, the University of Ioannina, and INESCTEC. Features VR, AR, and AI tools for clinical tele-rehabilitation, a catalogue of devices and services for self-management, and a developer layer for third-party integration.

4ULTREIA
CategoryTelerehabilitation Solution
Description

Phase 1 telerehabilitation solution developed by Bahia Software and Rehametric, providing an open ICT infrastructure for telerehabilitation technologies and a catalogue of telerehabilitation technologies with a development platform.

5RehabilityOpen
CategoryTelerehabilitation Solution
Description

Phase 1 telerehabilitation solution developed by the FORTH consortium, featuring a digital platform for personalised therapy design, remote patient monitoring, and secure telemonitoring channels with GDPR-compliant data handling.

6REHABILITA+
CategoryTelerehabilitation Solution
Description

Phase 1/2 telerehabilitation solution developed by GMV, featuring an Open Platform for coordinating care teams, shared care plans, personalised therapy plans, and patient self-management with mental health, nutrition, and monitoring services.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IACS is the main coordinator of the ROSIA project. Created in 2002, it is an independent public entity under the Aragon Health Department. Its mission is to promote research, innovation, and knowledge brokering in biomedicine and health sciences. IACS coordinates the joint procurement on behalf of the buyers group and holds responsibilities including Evidence Based Decision Making (EBDM), HTA agency functions, and support for biomedical research through its Project Office and 10 Research Core Facilities. Located at the Aragon Biomedical Research Centre (CIBA) in Zaragoza.

2SALUD (Servicio Aragonés de Salud)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SALUD is the public health provider for Aragón, Spain, with responsibilities for overall management and coordination of healthcare resources. It has 12 General Hospitals, 110 Primary Health Centres, and 5 Geriatric hospitals. It is one of the three public procurers and part of the buyers group. SALUD is a four-star reference site from the EIP on AHA (Active and Healthy Ageing), recognising its commitment to innovation for active and healthy ageing.

rosia-pcp.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NRH is Ireland's only hospital providing comprehensive specialist neuro-rehabilitation for patients following acquired brain injury, spinal cord injury, or amputation. Founded in 1961, it has 485 staff (FTE), annual turnover of approximately €41 million, and is accredited by CARF. It serves as a national provider of rehabilitation in Ireland and a procuring partner in the ROSIA project.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Coimbra Healthcare Integrated Delivery System unifies public health, primary care, and specialised services in Portugal with over 11,000 employees. It exemplifies integrated care and innovation, combining rehabilitation and palliative care with a seamless patient journey. The system collaborates with academic and research institutions and is a benchmark for integrated care in Portugal.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

VALDE is a Spanish consulting company with a network of senior collaborators specialised in innovation procurement (PPI and PCP) at European and national level. Since 2012, VALDE has developed expertise in ICT for Active and Healthy Aging and acts as procurement coordinator in the ROSIA project, providing expertise in European project management, co-creation methodologies, business development, and strategic procurement.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

IPN is a non-profit private organisation created in 1991 from the University of Coimbra. It promotes innovation through research and technological development, business incubation, and specialised training. IPN leads co-creation and co-design with end-users in ROSIA and is co-founder of the Ageing@Coimbra reference site of the EIP on AHA.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

IFIC is a not-for-profit network incorporated in the Netherlands that brings together academics, researchers, managers, practitioners, and policymakers to advance integrated care. IFIC leads the design of the telerehabilitation model in ROSIA and acts as a research and knowledge exchange hub.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

The Decision Group is a Dutch consultancy firm pioneering in Value-Based Healthcare since 2006. Led by Prof. Dr. Fred van Eenennaam, the team provides methodology based on Porter, Teisberg, and Kaplan's VBHC principles. In ROSIA, they are responsible for the Evaluation Framework.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

IEXP is the first organisation in Spain dedicated specifically to patient experience and one of Europe's reference organisations. All IEXP professionals come from the health or pharmaceutical field. IEXP engages patients in the solution co-creation process within ROSIA, focusing on ensuring technology produces real changes in patients' lives using PROMs and PREMs.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

PPCN is a health and care tech consultancy based in Copenhagen and Bangkok. It is responsible for the ICT functional specification in ROSIA and has vast experience in the healthy ageing tech market, with involvement in AI-based ageing tech, telehealth, HIS systems, and advanced medical device remote patient monitoring projects since 2007.

11Municipality of Penela
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Penela is a small municipality of about 135 km² in the Central Region of Portugal. It joined the European Network of Living Labs (ENoLL) in 2010 through the Smart Rural Living Lab project. In ROSIA, Penela supports piloting activities in its rural community.

rosia-pcp.eu
12Municipality of Soure
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Soure is a municipality of about 260 km² in the Central Region of Portugal near Coimbra, with around 20,000 inhabitants. It is involved as a pilot partner in ROSIA, supporting the testing of telerehabilitation solutions in its rural community settings.

rosia-pcp.eu
13Fundació Eurecat (Rehabilify solution)
Strategic tierCoreTypeTechnology or Integration
Description

Fundació Eurecat is a Spanish technology centre leading the Rehabilify solution in ROSIA Phase 3. The consortium also includes Doole Health (SME) and Germans Trias i Pujol research centre (IGTP). The solution proposes implementation of the ROSIA Open Platform with Patient Management System, AI services, and developer tools for rehabilitation technology integration.

rosia-pcp.eu
Strategic tierCoreTypeTechnology or Integration
Description

CERTH is a Greek research centre leading the RAISE solution in ROSIA Phase 3. The international consortium also integrates Spanish entities TELEVES, IBV, and Vidavo; Greek Research Committee University Ioannina (UoI); and Portuguese INESCTEC. RAISE proposes an open platform with VR, AR, and AI for telerehabilitation self-management.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

ROSIA is part of 2CARE4EU, a group of PCPs aiming to develop innovative healthcare ICT-based solutions for chronic disease treatment, remote rehabilitation, predictive analysis for frailty prevention, and integrated care for multimorbidity. The group has benefited from Horizon Results Booster support.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

CareMatrix is another PCP project in the 2CARE4EU group with which ROSIA collaborates on developing innovative healthcare solutions.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

eCare is another PCP project in the 2CARE4EU group collaborating with ROSIA on healthcare ICT solutions for integrated care.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

InCareHeart is another PCP project in the 2CARE4EU group collaborating with ROSIA on cardiovascular care and integrated solutions.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Eoh-for-Good facilitated the four co-creation sessions held in 2025 with ROSIA stakeholders (healthcare professionals, patients, developers, and procurers) to gather feedback on the telerehabilitation solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Telehealth platform for physical therapists providing remote patient monitoring, exercise prescription, and outcome tracking — directly comparable to ROSIA's remote rehabilitation service catalogue and clinician-facing tools.

TypeBroad incumbent
Description

Established UK-based provider of telecare and remote monitoring solutions for public health and social care; relevant as a scaled incumbent in the broader European home-care technology market ROSIA targets.

TypeOthers
Description

European health innovation accelerator/network under EIT; comparable as an adjacent enabling ecosystem that connects SMEs and procurement programmes (similar to ROSIA's matchmaking and OMC mechanisms) into European public healthcare.

TypeBroad incumbent
Description

Largest European digital primary care provider operating across multiple EU geographies; broad incumbent in telehealth whose scale and country coverage map to ROSIA's cross-border public healthcare procurement model.

TypeEmerging player
Description

Digital cognitive training and brain-health platform; partially comparable to ROSIA's acquired brain injury rehabilitation use case and its gamification/AI personalisation capabilities.

TypeDirect peer
Description

Digital MSK and rehabilitation platform combining AI-enabled virtual therapists and clinician oversight; directly comparable to ROSIA's home-based telerehabilitation and AI recommender approach across MSK and post-surgical indications.

TypeDirect peer
Description

Digital musculoskeletal care platform offering at-home exercise therapy, wearable sensors, and clinician coaching — closely comparable to ROSIA's home-care pathways, gamified exercise catalogue, and patient self-management focus.

TypeEmerging player
Description

European virtual ward and remote patient monitoring provider working with NHS and EU public systems; comparable to ROSIA's home-monitoring and shared-care-plan components in a commercial public-sector deployment context.

TypeDirect peer
Description

Digital therapeutic for MSK and COPD rehabilitation delivered via app with AI-driven motion analysis; comparable to ROSIA's AI recommender systems and COPD use case among its seven piloted pathologies.

TypeBroad incumbent
Description

Digital care platform for chronic conditions (cardiovascular, diabetes, MSK) combining coaching, wearable data, and clinician support — comparable to ROSIA's integrated care pathways and risk-stratification AI for cardiovascular rehabilitation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ROSIA-PCP

Telerehabilitation Software Platformrosia-pcp.eu

ROSIA-PCP is an EU Horizon 2020-funded Pre-Commercial Procurement project that develops an open telerehabilitation platform for patients in rural Europe. Coordinated by Spain's IACS and procured jointly by public health systems in Spain, Portugal, and Ireland.

What ROSIA-PCP does

ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative coordinated by the Instituto Aragonés de Ciencias de la Salud (IACS), a public research entity under the Aragon Health Department in Zaragoza, Spain. Funded by the European Commission's Horizon 2020 programme under grant agreement No 101017606, the project runs for 54 months (January 2021 through December 2025) with a €5 million budget, of which €3.9 million is allocated to a competitive three-phase R&D tender (Solution Design, Prototype Development, Field Testing). Its buyer group consists of three public healthcare procurers—Servicio Aragonés de Salud (Spain), Unidade Local de Saúde de Coimbra (Portugal), and the National Rehabilitation Hospital (Ireland)—who jointly steer the development of an open telerehabilitation platform for patients in rural and isolated parts of Europe. The 12-partner consortium spans five countries and includes research centres (Eurecat, CERTH/ITI, IGTP, IPN, IFIC), consultancies (VALDE Innova, The Decision Group, IEXP, PPCN), two Portuguese municipalities (Penela, Soure), and a facilitation partner (Eoh-for-Good).

The platform architecture is centred on an open integration layer that combines a service and device catalogue, SDK/APIs for third-party developers, a governance and quality-management system, and a shared care-plan interface for clinicians and patients. Functional components include patient self-management apps, AI-driven recommender systems across the four health pillars, decision support for risk stratification, VR/AR-enabled immersive rehabilitation, inertial-sensor-based monitoring, and a shared care plan with patient management for healthcare teams. Two Phase 3 solutions are being field-tested: REHABILIFY (led by Fundació Eurecat with Doole Health and IGTP) and RAISE (led by CERTH with TELEVES, IBV, Vidavo, University of Ioannina, and INESCTEC), covering seven pathologies—chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19—with over 100 patients piloted across rural Aragón, Coimbra, and Dublin.

The business model is public R&D procurement rather than commercial sales: ROSIA-PCP does not sell the platform; the three procurers act as anchor demand-side participants, and suppliers are selected through open competition. Marketing and stakeholder engagement span the project website, LinkedIn, X, Facebook, YouTube, newsletters, Open Market Consultation events, an online matchmaking platform, co-creation sessions, and a December 2025 end-of-project policy workshop with European Commission representation. Strategic positioning post-2025 depends on commercial uptake of the open platform by additional European public healthcare systems—a step that would be enabled by the certification, evidence, and policy outputs of the project but is not yet contracted.

ROSIA-PCP firmographics

Firmographics
Name
ROSIA-PCP
Legal name
Instituto Aragonés de Ciencias de la Salud (IACS)
Website
https://rosia-pcp.eu
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
ROSIA-PCP is an EU Horizon 2020-funded Pre-Commercial Procurement project that develops an open telerehabilitation platform for patients in rural Europe. Coordinated by Spain's IACS and procured jointly by public health systems in Spain, Portugal, and Ireland.
Ownership category
akta.pro rank

ROSIA-PCP industry classification

Industry
Product category
Telerehabilitation Software Platform
NAICS
Home Health Care Services (62161), Computer Systems Design and Related Services (5415), Scientific Research and Development Services (5417)
SIC
Services-Home Health Care Services (8082), Services-Computer Integrated Systems Design (7373), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

Keywords

  • Telerehabilitation platform
  • Open health ecosystem
  • Remote rehabilitation services
  • Digital health platform
  • Pre-commercial procurement

Where ROSIA-PCP is headquartered

Location

Headquarters

HQ city
Zaragoza
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

ROSIA-PCP business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels11 records

ROSIA-PCP product offering

Product offering

Core offering

ROSIA-PCP is a Pre-Commercial Procurement (PCP) project that designs, procures, and field-tests an open telerehabilitation platform for patients in rural and isolated areas of Europe. It jointly procures R&D services from technology providers across three European public healthcare systems (Spain, Portugal, Ireland) through a three-phase competitive process, ultimately delivering an open platform with a catalogue of integrated rehabilitation apps, services, and devices that supports patient self-management and clinical remote monitoring.

Product overview

ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative developing an open innovation platform for telerehabilitation in remote rural areas. The offering is structured as a platform-plus-modules architecture centered on the ROSIA Open Platform, which integrates third-party solutions through an app and service catalogue. Two main Phase 3 solutions (REHABILIFY and RAISE) are being field-tested alongside legacy Phase 1/2 solutions (PROHAB, ULTREIA, RehabilityOpen, REHABILITA+). The ecosystem includes patient self-management tools, AI-powered recommender systems, decision support for clinicians, and SDK/APIs for developers to build and integrate rehabilitation applications. Seven pathologies are targeted: chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardio-vascular disease, hip fracture, and COVID-19.

Differentiator

Problem solved

Functional benefit

Brands

  • Rehabilify: Telerehabilitation solution developed by a Spanish Consortium led by Fundació Eurecat, involving Doole Health and Germans Trias i Pujol research centre (IGTP)
  • RAISE

Products and services

  • ROSIA Open Platform The main ROSIA open telerehabilitation platform designed to integrate third-party solutions, devices, and apps into a catalogue for clinical prescription by healthcare professionals. It enables healthcare systems to deploy hybrid telerehabilitation services within integrated care pathways across rural and remote patient populations.
  • REHABILIFY (evolved from PROHAB) Phase 3 telerehabilitation solution developed by a Spanish consortium led by Fundació Eurecat, including Doole Health and Germans Trias i Pujol research centre (IGTP). Provides an open platform with a Patient Management System, AI recommender services, and SDK/APIs that enable third-party integration of rehabilitation technology.
  • RAISE Phase 3 telerehabilitation solution developed by an international consortium led by CERTH (Centre for Research and Technology Hellas), integrating TELEVES, IBV, Vidavo, the University of Ioannina, and INESCTEC. Features VR, AR, and AI tools for clinical tele-rehabilitation, a catalogue of devices and services for self-management, and a developer layer for third-party integration.
  • ULTREIA Phase 1 telerehabilitation solution developed by Bahia Software and Rehametric, providing an open ICT infrastructure for telerehabilitation technologies and a catalogue of telerehabilitation technologies with a development platform.
  • RehabilityOpen Phase 1 telerehabilitation solution developed by the FORTH consortium, featuring a digital platform for personalised therapy design, remote patient monitoring, and secure telemonitoring channels with GDPR-compliant data handling.
  • REHABILITA+ Phase 1/2 telerehabilitation solution developed by GMV, featuring an Open Platform for coordinating care teams, shared care plans, personalised therapy plans, and patient self-management with mental health, nutrition, and monitoring services.

Quantifiable outcome

  • Over 100 patients across Spain, Portugal, and Ireland tested the ROSIA solutions during the pilot phase, covering 7 pathologies including spinal cord injury, brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19.
  • +2 more outcomes

Companies that use ROSIA-PCP

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

ROSIA-PCP technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

ROSIA-PCP partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core and supporting.

  • IACS (Instituto Aragonés de Ciencias de la Salud)coreStrategic or Co-development PartnerIACS is the main coordinator of the ROSIA project. Created in 2002, it is an independent public entity under the Aragon Health Department. Its mission is to promote research, innovation, and knowledge brokering in biomedicine and health sciences. IACS coordinates the joint procurement on behalf of the buyers group and holds responsibilities including Evidence Based Decision Making (EBDM), HTA agency functions, and support for biomedical research through its Project Office and 10 Research Core Facilities. Located at the Aragon Biomedical Research Centre (CIBA) in Zaragoza.
  • SALUD (Servicio Aragonés de Salud)coreStrategic or Co-development PartnerSALUD is the public health provider for Aragón, Spain, with responsibilities for overall management and coordination of healthcare resources. It has 12 General Hospitals, 110 Primary Health Centres, and 5 Geriatric hospitals. It is one of the three public procurers and part of the buyers group. SALUD is a four-star reference site from the EIP on AHA (Active and Healthy Ageing), recognising its commitment to innovation for active and healthy ageing.
  • NRH (National Rehabilitation Hospital)coreStrategic or Co-development PartnerNRH is Ireland's only hospital providing comprehensive specialist neuro-rehabilitation for patients following acquired brain injury, spinal cord injury, or amputation. Founded in 1961, it has 485 staff (FTE), annual turnover of approximately €41 million, and is accredited by CARF. It serves as a national provider of rehabilitation in Ireland and a procuring partner in the ROSIA project.
  • ULS Coimbra (Unidade Local de Saúde de Coimbra)coreStrategic or Co-development PartnerThe Coimbra Healthcare Integrated Delivery System unifies public health, primary care, and specialised services in Portugal with over 11,000 employees. It exemplifies integrated care and innovation, combining rehabilitation and palliative care with a seamless patient journey. The system collaborates with academic and research institutions and is a benchmark for integrated care in Portugal.
  • VALDE InnovasupportingImplementation/ SI/ Consulting PartnerVALDE is a Spanish consulting company with a network of senior collaborators specialised in innovation procurement (PPI and PCP) at European and national level. Since 2012, VALDE has developed expertise in ICT for Active and Healthy Aging and acts as procurement coordinator in the ROSIA project, providing expertise in European project management, co-creation methodologies, business development, and strategic procurement.
  • Instituto Pedro Nunes (IPN)supportingStrategic or Co-development PartnerIPN is a non-profit private organisation created in 1991 from the University of Coimbra. It promotes innovation through research and technological development, business incubation, and specialised training. IPN leads co-creation and co-design with end-users in ROSIA and is co-founder of the Ageing@Coimbra reference site of the EIP on AHA.
  • IFIC (International Foundation for Integrated Care)supportingStrategic or Co-development PartnerIFIC is a not-for-profit network incorporated in the Netherlands that brings together academics, researchers, managers, practitioners, and policymakers to advance integrated care. IFIC leads the design of the telerehabilitation model in ROSIA and acts as a research and knowledge exchange hub.
  • The Decision GroupsupportingImplementation/ SI/ Consulting PartnerThe Decision Group is a Dutch consultancy firm pioneering in Value-Based Healthcare since 2006. Led by Prof. Dr. Fred van Eenennaam, the team provides methodology based on Porter, Teisberg, and Kaplan's VBHC principles. In ROSIA, they are responsible for the Evaluation Framework.
  • IEXP (Instituto para la Experiencia del Paciente)supportingStrategic or Co-development PartnerIEXP is the first organisation in Spain dedicated specifically to patient experience and one of Europe's reference organisations. All IEXP professionals come from the health or pharmaceutical field. IEXP engages patients in the solution co-creation process within ROSIA, focusing on ensuring technology produces real changes in patients' lives using PROMs and PREMs.
  • PPCN.xyz ApssupportingImplementation/ SI/ Consulting PartnerPPCN is a health and care tech consultancy based in Copenhagen and Bangkok. It is responsible for the ICT functional specification in ROSIA and has vast experience in the healthy ageing tech market, with involvement in AI-based ageing tech, telehealth, HIS systems, and advanced medical device remote patient monitoring projects since 2007.
  • Municipality of PenelasupportingStrategic or Co-development PartnerPenela is a small municipality of about 135 km² in the Central Region of Portugal. It joined the European Network of Living Labs (ENoLL) in 2010 through the Smart Rural Living Lab project. In ROSIA, Penela supports piloting activities in its rural community.
  • Municipality of SouresupportingStrategic or Co-development PartnerSoure is a municipality of about 260 km² in the Central Region of Portugal near Coimbra, with around 20,000 inhabitants. It is involved as a pilot partner in ROSIA, supporting the testing of telerehabilitation solutions in its rural community settings.
  • Fundació Eurecat (Rehabilify solution)coreTechnology or IntegrationFundació Eurecat is a Spanish technology centre leading the Rehabilify solution in ROSIA Phase 3. The consortium also includes Doole Health (SME) and Germans Trias i Pujol research centre (IGTP). The solution proposes implementation of the ROSIA Open Platform with Patient Management System, AI services, and developer tools for rehabilitation technology integration.
  • CERTH (Centre for Research and Technology Hellas / Ethniko Kentro - RAISE solution)coreTechnology or IntegrationCERTH is a Greek research centre leading the RAISE solution in ROSIA Phase 3. The international consortium also integrates Spanish entities TELEVES, IBV, and Vidavo; Greek Research Committee University Ioannina (UoI); and Portuguese INESCTEC. RAISE proposes an open platform with VR, AR, and AI for telerehabilitation self-management.
  • 2CARE4EU (PCP Group)supportingStrategic or Co-development PartnerROSIA is part of 2CARE4EU, a group of PCPs aiming to develop innovative healthcare ICT-based solutions for chronic disease treatment, remote rehabilitation, predictive analysis for frailty prevention, and integrated care for multimorbidity. The group has benefited from Horizon Results Booster support.
  • CareMatrixsupportingStrategic or Co-development PartnerCareMatrix is another PCP project in the 2CARE4EU group with which ROSIA collaborates on developing innovative healthcare solutions.
  • eCare PCPsupportingStrategic or Co-development PartnereCare is another PCP project in the 2CARE4EU group collaborating with ROSIA on healthcare ICT solutions for integrated care.
  • InCareHeartsupportingStrategic or Co-development PartnerInCareHeart is another PCP project in the 2CARE4EU group collaborating with ROSIA on cardiovascular care and integrated solutions.
  • Eoh-for-GoodsupportingImplementation/ SI/ Consulting PartnerEoh-for-Good facilitated the four co-creation sessions held in 2025 with ROSIA stakeholders (healthcare professionals, patients, developers, and procurers) to gather feedback on the telerehabilitation solutions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

ROSIA-PCP competitors and assessment

Company assessment

Direct peers

  • Physitrack: Telehealth platform for physical therapists providing remote patient monitoring, exercise prescription, and outcome tracking — directly comparable to ROSIA's remote rehabilitation service catalogue and clinician-facing tools.
  • Sword Health: Digital MSK and rehabilitation platform combining AI-enabled virtual therapists and clinician oversight; directly comparable to ROSIA's home-based telerehabilitation and AI recommender approach across MSK and post-surgical indications.
  • Hinge Health: Digital musculoskeletal care platform offering at-home exercise therapy, wearable sensors, and clinician coaching — closely comparable to ROSIA's home-care pathways, gamified exercise catalogue, and patient self-management focus.
  • Kaia Health: Digital therapeutic for MSK and COPD rehabilitation delivered via app with AI-driven motion analysis; comparable to ROSIA's AI recommender systems and COPD use case among its seven piloted pathologies.

Broad incumbents

  • Tunstall Healthcare: Established UK-based provider of telecare and remote monitoring solutions for public health and social care; relevant as a scaled incumbent in the broader European home-care technology market ROSIA targets.
  • KRY (Livi): Largest European digital primary care provider operating across multiple EU geographies; broad incumbent in telehealth whose scale and country coverage map to ROSIA's cross-border public healthcare procurement model.
  • Omada Health: Digital care platform for chronic conditions (cardiovascular, diabetes, MSK) combining coaching, wearable data, and clinician support — comparable to ROSIA's integrated care pathways and risk-stratification AI for cardiovascular rehabilitation.

Others

  • EIT Health: European health innovation accelerator/network under EIT; comparable as an adjacent enabling ecosystem that connects SMEs and procurement programmes (similar to ROSIA's matchmaking and OMC mechanisms) into European public healthcare.

Emerging players

  • NeuroNation: Digital cognitive training and brain-health platform; partially comparable to ROSIA's acquired brain injury rehabilitation use case and its gamification/AI personalisation capabilities.
  • Doccla: European virtual ward and remote patient monitoring provider working with NHS and EU public systems; comparable to ROSIA's home-monitoring and shared-care-plan components in a commercial public-sector deployment context.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

ROSIA-PCP social profiles

Digital presence

ROSIA-PCP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ROSIA-PCP leadership team

Management profile

Number of profiles

ROSIA-PCP funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ROSIA-PCP M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ROSIA-PCP

What does ROSIA-PCP do?

ROSIA-PCP is a Pre-Commercial Procurement (PCP) project that designs, procures, and field-tests an open telerehabilitation platform for patients in rural and isolated areas of Europe. It jointly procures R&D services from technology providers across three European public healthcare systems (Spain, Portugal, Ireland) through a three-phase competitive process, ultimately delivering an open platform with a catalogue of integrated rehabilitation apps, services, and devices that supports patient self-management and clinical remote monitoring.

Is ROSIA-PCP a public or private company?

ROSIA-PCP is a private company. It is classified as unknown and is currently operating.

When was ROSIA-PCP founded?

ROSIA-PCP was founded in 2021. It employs 11 to 50 people.

Where is ROSIA-PCP based?

ROSIA-PCP is headquartered in Zaragoza, Spain, in the Europe region.

Who are ROSIA-PCP's main competitors?

Direct peers on record are Physitrack, Sword Health, Hinge Health and Kaia Health. Broad incumbents are Tunstall Healthcare, KRY (Livi) and Omada Health. EIT Health is listed as an others. Emerging players are NeuroNation and Doccla.

Does ROSIA-PCP have an API?

No public API is recorded for ROSIA-PCP.

What industry is ROSIA-PCP in?

ROSIA-PCP's product category is Telerehabilitation Software Platform. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales